SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is trending as the community actively rallies to drive market cap growth and secure a dedicated chart, drawing parallels to other high-volatility meme coins. Investors are heavily focused on holding through early whale activity, emphasizing collective buying power to push the project toward broader visibility and long-term momentum.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae is experiencing significant volatility and trending discussions as investors react to high-profile advocacy from Bill Ackman and Michael Burry, who characterize the stock as significantly undervalued. The community remains deeply divided, with some traders optimistic about potential government policy shifts or an exit from conservatorship, while others express frustration over stagnant timelines and the risks associated with headline-driven price action.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is experiencing bearish pressure as market participants react to lackluster weight-loss clinical trial results and ongoing concerns regarding the company's patent cliff and debt load. Despite these headwinds, the community remains divided, with some investors leveraging the stock's dividend and defensive profile for income, while others remain skeptical of management's ability to drive meaningful share price appreciation.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors digest a mixed earnings report that highlighted a pivot away from the Chinese market and a new long-term magnet supply agreement with Apple. The community remains focused on the company's role in domestic supply chain security, debating the impact of increased production costs and capital expenditure against long-term government partnerships and defense-sector demand.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy (GLND) is seeing intense trading volume and volatility as speculators bet on its Arctic oil exploration potential amid rising geopolitical tensions. The community remains sharply divided, with bulls highlighting the strategic value of its Jameson Land Basin drilling rights and partnership with major industry players, while skeptics warn of potential SPAC-related dilution and risks inherent in frontier exploration.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

$AIRCOIN is gaining significant traction on Solana as the community champions its "PvE" (Player vs. Environment) narrative, highlighting a voluntary supply lock of over 40% as a sign of strong, anti-rug conviction. Investors are actively discussing the project's consistent growth, treasury-building efforts, and the belief that its long-term, community-led structure sets it apart from typical, short-lived meme cycles.

Freddie Mac engages in the provision of housing finance system solutions. It operates through the Single-Family and Multifamily segments. The Single-Family segment is involved in purchase, securitization, and guarantee of single-family loans, investments, and management of single-family mortgage credit risk and market risk. The Multifamily segment focuses on purchase, securitization, and guarantee of multifamily loans, investments, securities, and management of multifamily mortgage credit risk and market risk. The company was founded on July 24, 1970 and is headquartered in McLean, VA.

Federal Home Loan Mortgage Corp

Freddie Mac

Freddie Mac (FMCC) and Fannie Mae are trending as investors speculate on a potential path out of government conservatorship, fueled by high-profile endorsements from Bill Ackman and Michael Burry. The community is heavily focused on the prospect of a major relisting on the NYSE, with active discussions debating whether the current market movement represents a fundamental rerating or a high-stakes political trade on future administration policy.

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Phreesia Inc

Phreesia shares are reeling after the company lowered its fiscal 2027 revenue outlook, triggering significant investor disappointment and community concerns regarding the firm's growth trajectory. The stock is facing heavy downward pressure as traders debate whether the current selloff represents a deep-value opportunity or a sign of broader struggles within the SaaS sector.

Progress Software Corp. engages in the provision of products that develop and deploy mission-critical business applications. Its products and solutions include Chef, Corticon, DataDirect, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity & WhatsUp Gold. The company was founded by Joseph Wright Alsop, Clyde Kessel, and Charles Arthur Ziering in 1981 and is headquartered in Burlington, MA.

Progress Software Corp.

Progress Software is facing mixed investor sentiment as it balances solid earnings growth driven by product demand against concerns over soft forward-looking guidance and a sizeable debt load from its ShareFile acquisition. While analysts remain largely optimistic about the firm's long-term potential as an infrastructure software player, the community is actively debating whether the recent share price volatility represents a buying opportunity or a warning sign of an overvalued stock facing integration challenges.

Sysco Corp. engages in the selling, marketing, and distribution of food products to restaurants, healthcare and educational facilities, and lodging establishments. It operates through the following segments: U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other. The U.S. Foodservice Operations segment consists of U.S. Broadline operations, custom-cut meat and seafood companies, FreshPoint, and European Imports. The International Foodservice Operations segment includes operations outside of the United States which distribute a full line of food products and a wide variety of non-food products. The SYGMA segment represents U.S. customized distribution operations serving quick-service chain restaurant customer locations. The Other segment covers hotel supply operations. The company was founded by John F. Baugh in 1969 and is headquartered in Houston, TX.

Sysco Corp.

Sysco shares are trending lower as investors digest the implications of a massive $29.1 billion acquisition of Jetro Restaurant Depot, fueling debates about the long-term strategic benefits of market consolidation versus the risks of significant share dilution and increased debt. While some in the community see the scale and high-margin potential of this move as a prime opportunity to buy the dip, others remain cautious, citing concerns over integration challenges and the broader health of the restaurant sector in a potential recession.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cathie Wood sells $2.1 million of megacap tech stock

CRISPR Therapeutics (NASDAQ:CRSP) General Counsel Sells $148,853.96 in Stock

CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) General Counsel James Kasinger sold 3,182 shares of the firm's stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $46.78, for a total value of $148,853.96. Following the transaction, the...

Truist Financial Upgrades CRISPR Therapeutics (NASDAQ:CRSP) to "Strong-Buy"

Truist Financial upgraded shares of CRISPR Therapeutics to a "strong-buy" rating in a research note on Wednesday...

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $47.09, moving +1.42% from the previous trading session.

CRISPR Therapeutics (NASDAQ:CRSP) General Counsel James Kasinger Sells 3,182 Shares

CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) General Counsel James Kasinger sold 3,182 shares of the stock in a transaction dated Monday, March 23rd. The shares were sold at an average...

Anti-Aging Protein Research Takes a Step Forward with Cell Cloning

Anti-Aging Protein Research Takes a Step Forward with Cell Cloning Anti-Aging Protein Research Takes a Step Forward with Cell Cloning PR Newswire VANCOUVER, BC, March 24, 2026 Issued on behalf of Ava...

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?

Key PointsCRISPR recently raised nearly $600 million through a private offering, which weighed down its share price...

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Consensus Rating of "Hold" from Analysts

CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) has been assigned an average rating of "Hold" from the eighteen research firms that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, six have given a hold recommendation an...

JPMorgan Chase & Co. Has $38.46 Million Holdings in CRISPR Therapeutics AG $CRSP

JPMorgan Chase & Co. lifted its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 98.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 593,416 shares of the company's stock afte...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

CRSP
CRISPR Therapeutics AG

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CRSP News

CRSPCRISPR Therapeutics AG